Form 4: Gabelli Director Boosts Stake in Healthcare & WellnessRx Trust
Insider Transaction Report
Mario J. Gabelli, a director and control person, increased his indirect beneficial ownership in Gabelli Healthcare & WellnessRx Trust through purchases totaling 4,810 common shares.
Summary
- Mario J. Gabelli, a director, 10% owner, and control person of the adviser for Gabelli Healthcare & WellnessRx Trust (GRX), reported transactions.
- On January 12, 2026, Gabelli indirectly acquired 3,800 common shares of Gabelli Healthcare & WellnessRx Trust at a price of $9.58 per share through GGCP, Inc.
- On the same date, an additional 1,010 common shares were indirectly acquired at $9.58 per share through Associated Capital Group, Inc.
- Following these transactions, the total indirect beneficial ownership attributed to Gabelli includes 316,026 shares via GGCP, Inc., 10,000 shares via Associated Capital Group, Inc., 6,380 shares via GPJ Retirement Partners, and 3,000 shares via Trust Accounts.
- Gabelli disclaims beneficial ownership of shares held by GGCP, Inc., Associated Capital Group, Inc., and GPJ Retirement Partners, LLC, in excess of his indirect pecuniary interest.
Sentiment
Score: 7
Explanation: The insider buying by a significant director and 10% owner suggests confidence in the company's prospects, which is generally a positive signal for investors.
Positives
- A director and significant owner, Mario J. Gabelli, increased his stake in the company, signaling confidence in its future prospects.
- The purchases were made at a specific price of $9.58 per share, indicating a valuation point at which the insider found the shares attractive.
Future Outlook
NA
Industry Context
This insider transaction reflects a specific investment decision by a key individual within the Gabelli organization, rather than a broad industry trend. However, it occurs within the context of the healthcare and wellness sector, which is subject to its own unique market dynamics and regulatory environment.
Related Party Transactions
- Acquisition of shares through GGCP, Inc., where Mario J. Gabelli is the Chief Executive Officer, a director, and the controlling shareholder.
- Acquisition of shares through Associated Capital Group, Inc., where Mario J. Gabelli is the Executive Chair and controlling shareholder.
- Beneficial ownership through GPJ Retirement Partners, LLC, a limited liability company where Mr. Gabelli has less than a 100% interest.
- Beneficial ownership through trust accounts for which Mario J. Gabelli serves as trustee.
Stakeholder Impact
- Shareholders: The insider buying by a key director and 10% owner may instill increased confidence in the company's valuation and future performance.
Key Dates
| Date | Description |
|---|---|
| 01/12/2026 | Transaction Date for common shares acquired by GGCP, Inc. and Associated Capital Group, Inc. |
| 01/14/2026 | Signature Date of the reporting person's attorney-in-fact. |
Recommendation
holdThe reported insider purchases by Mario J. Gabelli, a director and significant owner, indicate management's confidence in the Gabelli Healthcare & WellnessRx Trust. While this is a positive signal, a Form 4 filing primarily details transactions and does not provide a comprehensive financial overview or strategic update to warrant a 'buy' or 'sell' recommendation. The purchases at $9.58 per share suggest a belief in value at that price point, supporting a 'hold' position for existing investors and a closer look for potential new investors.
Keywords
Gabelli Healthcare & WellnessRx Trust, GRX, Mario J. Gabelli, Insider Buying, Form 4, Beneficial Ownership, Healthcare Investment, Closed-End Fund
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.